Methylation and Polymorphism in CDH1 Gene Promoter Among Patients with Diffuse Gastric Cancer

Mohadeseh Naghi Vishteh, Mehrdad Zeinalian, Majid Kheirollahi, Amirreza Javadi Mamaghani, Mohammad Ali Zolfaghari, Aliyar Mirzapour, Meisam Barati, Seyed Javad Seyed Tabaei


Background: The promoter methylation and single nucleotide polymorphisms (SNPs) affect the transcription activity of cancer‑related genes in several cancers including diffuse gastric cancer (DGC). Here we aimed to evaluate the promoter methylation status and the rs16260 at the promoter region of the CDH1 gene in DGC. Methods: This case‑control study was performed of 48 formalin‑fixed paraffin‑embedded (FFPE) blocks of DGC patients and 41 fresh frozen tissue samples of healthy individuals. Methylation status was evaluated using methylation‑specific polymerase chain reaction (PCR) and the rs16260 at the promoter region of the CDH1 gene was assessed using PCR and sequencing method. Results: The occurrence of methylation at the promoter region of the CDH1 gene in DGC patients was significantly higher than control samples (P < 0.0001). The methylated status was significantly associated with the poor differentiated histological type of DGC (P = 0.0428). The frequency of AC genotype and the A allele in DGC patients was significantly higher than the control subjects (P = 0.006 and 0.003, respectively). Conclusions: Here we showed that methylation at the CDH1 promoter may contribute to the DGC development, and also the AC genotype was associated with the risk of DGC.


Cadherin 1; methylation; polymerase chain reaction; sequence analysis; stomach neoplasms

Full Text:



Malekzadeh R, Derakhshan MH, Malekzadeh Z. Gastric

cancer in Iran: Epidemiology and risk factors. Arch Iran Med


Rawla P, Barsouk A. Epidemiology of gastric cancer:

Global trends, risk factors and prevention. Prz Gastroenterol


Gullo I, Carneiro F, Oliveira C, Almeida GM. Heterogeneity

in gastric cancer: From pure morphology to molecular

classifications. Pathobiology 2018;85:50‑63.

Nobili S, Bruno L, Landini I, Napoli C, Bechi P, Tonelli F, et al.

Genomic and genetic alterations influence the progression of

gastric cancer. World J Gastroenterol 2011;17:290‑9.

Ansari S, Gantuya B, Tuan VP, Yamaoka Y. Diffuse gastric

cancer: A summary of analogous contributing factors for its

molecular pathogenicity. Int J Mol Sci 2018;19:2424.

Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R,

Polkowski WP. Gastric cancer: Epidemiology, prevention,

classification, and treatment. Cancer Manag Res 2018;10:239‑48.

van der Post RS, Vogelaar IP, Carneiro F, Guilford P,

Huntsman D, Hoogerbrugge N, et al. Hereditary diffuse gastric

cancer: Updated clinical guidelines with an emphasis on germline

CDH1 mutation carriers. J Med Genet 2015;52:361‑74.

Lu Y, Xu YC, Shen J, Yu RB, Niu JY, Guo JT, et al. E‑cadherin

gene C‑160A promoter polymorphism and risk of non‑cardia

gastric cancer in a Chinese population. World J Gastroenterol


Pecina‑Slaus N. Tumor suppressor gene E‑cadherin and its role

in normal and malignant cells. Cancer Cell Int 2003;3:17.

Jenab M, McKay JD, Ferrari P, Biessy C, Laing S,

Munar GM, et al. CDH1 gene polymorphisms, smoking,

Helicobacter pylori infection and the risk of gastric cancer

in the European Prospective Investigation into Cancer and

Nutrition (EPIC‑EURGAST). Eur J Cancer 2008;44:774‑80.

Sharma S, Kelly TK, Jones PA. Epigenetics in cancer.

Carcinogenesis 2010;31:27‑36.

Fu DG. Epigenetic alterations in gastric cancer (Review). Mol

Med Rep 2015;12:3223‑30.

Machado JC, Oliveira C, Carvalho R, Soares P, Berx G,

Caldas C, et al. E‑cadherin gene (CDH1) promoter methylation

as the second hit in sporadic diffuse gastric carcinoma. Oncogene


Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira‑Carrico R,

Senz J, et al. Quantification of epigenetic and genetic 2nd hits

in CDH1 during hereditary diffuse gastric cancer syndrome

progression. Gastroenterology 2009;136:2137‑48.

Imtiaz H, Afroz S, Hossain MA, Bellah SF, Rahman MM,

Kadir MS, et al. Genetic polymorphisms in CDH1 and

Exo1 genes elevate the prostate cancer risk in Bangladeshi

population. Tumour Biol 2019;41:1010428319830837. doi:


Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA,

Jemal A. Global cancer statistics 2018: GLOBOCAN estimates

of incidence and mortality worldwide for 36 cancers in 185

countries. CA Cancer J Clin 2018;68:394‑424.

Khushalani N. Cancer of the esophagus and stomach. Mayo Clin

Proc 2008;83:712‑22.

Salavati S, Ahmadi Hedayati M, Ahmadi A, Fakhari S, Jalili A.

Relationship between Helicobacter pylori cagA genotypes

infection and IL‑10 and TGFβ1 Genes’ Expression in gastric

epithelial cells. International journal of preventive medicine


Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH,

et al. Promoter methylation of E‑cadherin gene in gastric mucosa

associated with Helicobacter pylori infection and in gastric

cancer. Gut 2003;52:502‑6.

Wijnhoven BP, Dinjens WN, Pignatelli M. E‑cadherin‑catenin

cell‑cell adhesion complex and human cancer. Br J Surg


Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N,

Harawira P, et al. E‑cadherin germline mutations in familial

gastric cancer. Nature 1998;392:402‑5.

Humar B, Graziano F, Cascinu S, Catalano V, Ruzzo AM,

Magnani M, et al. Association of CDH1 haplotypes with

susceptibility to sporadic diffuse gastric cancer. Oncogene


Lee KH, Hwang D, Kang KY, Lee S, Kim DY, Joo YE, et al.

Frequent promoter methylation of CDH1 in non‑neoplastic

mucosa of sporadic diffuse gastric cancer. Anticancer Res


Zhao L, Wang YX, Xi M, Liu SL, Zhang P, Luo LL, et al.

Association between E‑cadherin (CDH1) polymorphisms and

pancreatic cancer risk in Han Chinese population. Int J Clin Exp

Pathol 2015;8:5753‑60.

Pharoah PD, Guilford P, Caldas C. International gastric cancer

linkage C. Incidence of gastric cancer and breast cancer in

CDH1 (E‑cadherin) mutation carriers from hereditary diffuse

gastric cancer families. Gastroenterology 2001;121:1348‑53.

Kalantari S, Tafrihi M, Shokrzadeh M. Association of the ‑160

C>A Polymorphism in the CDH1 promoter with gastric cancer:

A case‑control study. J Genetic Res 2019;5:1‑8.

Al‑Moundhri MS, Al‑Khanbashi M, Al‑Kindi M, Al‑Nabhani M,

Burney IA, Al‑Farsi A, et al. Association of E‑cadherin (CDH1)

gene polymorphisms and gastric cancer risk. World J

Gastroenterol 2010;16:3432‑6.

Wang Q, Gu D, Wang M, Zhang Z, Tang J, Chen J. The

E‑cadherin (CDH1) ‑160C>A polymorphism associated with

gastric cancer among Asians but not Europeans. DNA Cell Biol


Zhan Z, Wu J, Zhang JF, Yang YP, Tong S, Zhang CB, et al.

CDH1 gene polymorphisms, plasma CDH1 levels and risk

of gastric cancer in a Chinese population. Mol Biol Rep